Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Area of Science:

• Immunology
• Vaccinology
• Biotechnology

Background:

• Oral and nasal antigen administration can induce immune tolerance, a significant obstacle for developing effective mucosal vaccines.
• Despite challenges, the demand for convenient, pain-free mucosal vaccines that elicit local and systemic immunity drives research and development.
• Current mucosal vaccines face caution, especially those using live organisms, limiting market availability.

Purpose of the Study:

• To review the use of delivery systems with adjuvant properties in mucosal vaccine strategies.
• To explore methods for overcoming immune tolerance induced by oral and nasal antigen administration.
• To highlight successful non-live vector approaches in nasal and oral mucosal vaccines.

Main Methods:

• Literature review focusing on adjuvant delivery systems for mucosal vaccines.
• Analysis of strategies to circumvent immune tolerance via mucosal routes.
• Examination of vaccine development for nasal and oral administration.

Main Results:

• Adjuvant delivery systems are key components in successful mucosal vaccine strategies.
• Non-live vector approaches can effectively overcome immune tolerance.
• Successful examples of mucosal vaccines utilizing nasal and oral routes were identified.

Conclusions:

• Adjuvant delivery systems offer a promising strategy for developing effective mucosal vaccines without live vectors.
• Overcoming immune tolerance is achievable through carefully designed delivery systems for oral and nasal administration.
• Further development of these strategies could lead to safer and more convenient mucosal vaccine options.